|
gptkbp:instance_of
|
gptkb:Android
|
|
gptkbp:administered_by
|
oral tablet
|
|
gptkbp:can_be_used_to
|
osteoporosis treatment
age-related muscle loss
|
|
gptkbp:casnumber
|
841205-47-8
|
|
gptkbp:chemical_formula
|
C19 H14 Cl N3 O3 S
|
|
gptkbp:class
|
non-steroidal compound
|
|
gptkbp:clinical_trial
|
gptkb:Australia
gptkb:Brazil
gptkb:Canada
gptkb:France
gptkb:Germany
gptkb:India
gptkb:Japan
gptkb:South_Korea
gptkb:United_Kingdom
gptkb:United_States
Phase II
|
|
gptkbp:composed_by
|
gptkb:chemical_compound
organic chemistry
|
|
gptkbp:developed_by
|
gptkb:GTx,_Inc.
|
|
gptkbp:first_described_by
|
gptkb:2011
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Enobosarm
|
|
gptkbp:invention
|
patented
|
|
gptkbp:knockouts
|
high for androgen receptors
|
|
gptkbp:marketed_as
|
gptkb:Ostarine
|
|
gptkbp:mechanism_of_action
|
androgen receptor agonist
|
|
gptkbp:not_approved_in
|
gptkb:European_Union
gptkb:United_States
|
|
gptkbp:regulatory_compliance
|
investigational drug
|
|
gptkbp:related_to
|
gptkb:anabolic_steroids
performance-enhancing drugs
bodybuilding supplements
|
|
gptkbp:research_focus
|
performance enhancement
muscle preservation
|
|
gptkbp:side_effect
|
fatigue
headache
nausea
muscle cramps
increased liver enzymes
|
|
gptkbp:structure
|
thiazole ring
pyrimidine ring
chlorophenyl group
|
|
gptkbp:target_audience
|
cancer patients
HIV patients
|
|
gptkbp:used_for
|
muscle wasting
cachexia
|
|
gptkbp:bfsParent
|
gptkb:GTx,_Inc.
|
|
gptkbp:bfsLayer
|
8
|